Frequently Asked Questions
Omsk Hemorrhagic Fever (OHF) Treatment Market is growing at a CAGR of 6.80% by 2028.
Asia-Pacific is expected to account for the largest market share owing to increasing rodent species and increasing number of travellers is an another factor boosting the Asia Pacific market.
The major players covered in the Omsk hemorrhagic fever (OHF) treatment market are Nortec Quimica, Bausch Health Companies Inc., Zydus Cadila, Hetero Healthcare Limited, AdvaCare Pharma, Aurobindo Pharma, Wellona Pharma, LUPIN, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Baxter among other domestic and global players.
